603658 安图生物
已收盘 07-29 15:00:00
资讯
新帖
简况
安图生物(603658)7月23日主力资金净卖出142.37万元
证券之星 · 07-24
安图生物(603658)7月23日主力资金净卖出142.37万元
安图生物获得实用新型专利授权:“幽门螺旋杆菌分型检测用自测试剂盒”
证券之星 · 07-24
安图生物获得实用新型专利授权:“幽门螺旋杆菌分型检测用自测试剂盒”
北向资金7月19日净买入安图生物22.35万股 连续3日增持
自选股智能写手 · 07-22
北向资金7月19日净买入安图生物22.35万股 连续3日增持
安图生物(603658)7月17日主力资金净卖出281.82万元
证券之星 · 07-18
安图生物(603658)7月17日主力资金净卖出281.82万元
安图生物07月15日主力资金流入38万元 连续3日加仓
自选股智能写手 · 07-15
安图生物07月15日主力资金流入38万元 连续3日加仓
病毒检测概念盘中跳水,安图生物跌1.05%
自选股智能写手 · 07-15
病毒检测概念盘中跳水,安图生物跌1.05%
北向资金7月10日净卖出安图生物21.35万股 连续3日减持
自选股智能写手 · 07-11
北向资金7月10日净卖出安图生物21.35万股 连续3日减持
安图生物:7月9日高管苗拥军增持股份合计3000股
证券之星 · 07-10
安图生物:7月9日高管苗拥军增持股份合计3000股
北向资金7月5日净买入安图生物4.22万股 连续3日增持
自选股智能写手 · 07-08
北向资金7月5日净买入安图生物4.22万股 连续3日增持
安图生物:7月3日高管苗拥军增持股份合计2万股
证券之星 · 07-04
安图生物:7月3日高管苗拥军增持股份合计2万股
安图生物:7月2日高管苗拥军增持股份合计5.5万股
证券之星 · 07-03
安图生物:7月2日高管苗拥军增持股份合计5.5万股
安图生物: 公司目前生产经营一切正常,敬请投资者注意投资风险
证券之星 · 07-03
安图生物: 公司目前生产经营一切正常,敬请投资者注意投资风险
安图生物:公司目前生产经营一切正常
每日经济新闻 · 07-03
安图生物:公司目前生产经营一切正常
北向资金7月2日净卖出安图生物25.67万股 连续3日减持
自选股智能写手 · 07-03
北向资金7月2日净卖出安图生物25.67万股 连续3日减持
安图生物获融资买入0.11亿元,近三日累计买入0.24亿元
金融界 · 07-02
安图生物获融资买入0.11亿元,近三日累计买入0.24亿元
安图生物董事苗拥军增持2.40万股,成交均价46.09元
金融界 · 07-01
安图生物董事苗拥军增持2.40万股,成交均价46.09元
安图生物:6月28日高管苗拥军增持股份合计2.4万股
证券之星 · 07-01
安图生物:6月28日高管苗拥军增持股份合计2.4万股
安图生物:累计回购约412万股
每日经济新闻 · 07-01
安图生物:累计回购约412万股
安图生物(603658.SH)取得14项医疗器械注册证
智通财经 · 07-01
安图生物(603658.SH)取得14项医疗器械注册证
安图生物最新公告:近日收到河南省药品监督管理局颁发的医疗器械注册证
证券之星 · 07-01
安图生物最新公告:近日收到河南省药品监督管理局颁发的医疗器械注册证
暂无数据
公司概况
公司名称:
郑州安图生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2016-09-01
主营业务:
郑州安图生物工程股份有限公司专业从事体外诊断试剂及仪器的研发、制造、整合及服务,产品涵盖免疫、微生物、生化等检测领域,同时也在分子检测等领域积极布局,能够为医学实验室提供全面的产品解决方案和整体服务。公司产品按照检测方法或应用领域分类,主要分为以下几类:免疫类诊断试剂、微生物检测试剂、生化检测试剂、分子检测试剂、免疫类、微生物类、分子类、临床检验及其他辅助设备。公司产品覆盖了从传染病到非传染病的诸多方向,是我国业内提供免疫检测产品较多的企业之一,也是国内能够提供全面免疫检测解决方案的企业之一。
发行价格:
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":40.55,"timestamp":1722236400000,"preClose":41.74,"halted":0,"volume":3174816,"delay":0,"floatShares":581000000,"shares":581000000,"eps":2.2368,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.19,"latestTime":"07-29 15:00:00","open":41.6,"high":41.69,"low":40.45,"amount":130000000,"amplitude":0.0297,"askPrice":40.56,"askSize":1,"bidPrice":40.55,"bidSize":19,"shortable":0,"etf":0,"ttmEps":2.2368,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722303000000},"adr":0,"adjPreClose":41.74,"symbolType":"stock","openAndCloseTimeList":[[1722216600000,1722223800000],[1722229200000,1722236400000]],"highLimit":45.91,"lowLimit":37.57,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":581011346,"pbRate":2.68,"roa":"--","roe":"3.74%","epsLYR":2.1,"committee":0.612903,"marketValue":23560000000,"floatMarketCap":23560000000,"peRate":18.128577,"changeRate":-0.0285,"turnoverRate":0.0055,"status":1},"requestUrl":"/m/hq/s/603658/tweets","defaultTab":"tweets","newsList":[{"id":"2453013577","title":"安图生物(603658)7月23日主力资金净卖出142.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453013577","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453013577?lang=zh_cn&edition=full","pubTime":"2024-07-24 08:26","pubTimestamp":1721780796,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月23日收盘,安图生物报收于41.75元,下跌4.46%,换手率0.87%,成交量5.08万手,成交额2.14亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入2168.66万元,融资偿还1652.51万元,融资净买入516.16万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400015877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2453069474","title":"安图生物获得实用新型专利授权:“幽门螺旋杆菌分型检测用自测试剂盒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2453069474","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453069474?lang=zh_cn&edition=full","pubTime":"2024-07-24 02:46","pubTimestamp":1721760394,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示安图生物新获得一项实用新型专利授权,专利名为“幽门螺旋杆菌分型检测用自测试剂盒”,专利申请号为CN202322422313.3,授权日为2024年7月9日。本实用新型优点在于能够便捷地实现人体血液样本的采集,进而轻松完成血液样本的幽门螺杆菌检测和分型,方便自行完成检测。今年以来安图生物新获得专利授权20个,较去年同期减少了35.48%。结合公司2023年年报财务数据,2023年公司在研发方面投入了6.56亿元,同比增15.42%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400003550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2453978845","title":"北向资金7月19日净买入安图生物22.35万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453978845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453978845?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:30","pubTimestamp":1721611832,"startTime":"0","endTime":"0","summary":"7月19日, 北向资金增持安图生物22.35万股,连续3日增持。截止当日收盘,沪股通共持有安图生物1350.56万股,占流通股2.32%。沪股通增持金额前五个股分别为XD江淮汽、赤峰黄金、中金黄金、北汽蓝谷、伊利股份。安图生物近5个交易日下跌0.57%,沪股通累计增持55.79万股;近20个交易日下跌7.28%,沪股通累计减持140.68万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220934129edd4ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220934129edd4ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2452665112","title":"安图生物(603658)7月17日主力资金净卖出281.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452665112","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452665112?lang=zh_cn&edition=full","pubTime":"2024-07-18 08:13","pubTimestamp":1721261637,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月17日收盘,安图生物报收于44.66元,上涨2.83%,换手率0.6%,成交量3.46万手,成交额1.54亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入605.36万元,融资偿还1154.51万元,融资净偿还549.15万元。融券方面,融券卖出1600.0股,融券偿还5100.0股,融券余量63.84万股,融券余额2851.14万元。安图生物主营业务:专业从事体外诊断试剂及仪器的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800012964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2451697162","title":"安图生物07月15日主力资金流入38万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2451697162","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451697162?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:19","pubTimestamp":1721027993,"startTime":"0","endTime":"0","summary":"07月15日, 安图生物股价跌0.84%,报收43.55元,成交金额9138万元,换手率0.36%,振幅1.80%,量比0.66。安图生物今日主力资金净流入38万元,连续3日净流入,上一交易日主力净流入112万元,今日环比减少66.07%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为33.33%,平均涨幅为1.44%。该股近5个交易日上涨0.69%,主力资金累计净流入1797万元,其中3个交易日为股价下跌时净流入;近20日主力资金累计净流出470万元,其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151537319f4d6732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407151537319f4d6732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2451566604","title":"病毒检测概念盘中跳水,安图生物跌1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451566604","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451566604?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:24","pubTimestamp":1721010249,"startTime":"0","endTime":"0","summary":"07月15日,病毒检测概念盘中跳水,截至10点24分,病毒检测概念整体指数下跌2.03%,报733.600点。从个股上来看,该概念的成分股中,安图生物跌1.05%,万泰生物、新产业、丽珠集团跌幅居前。从资金上来看,截止发稿,病毒检测概念主力净流入为-9143.17万,其中万孚生物受到资金热捧,主力净流入271.09万;拉长时间线来看,该板块近20日主力资金净流入-14.08亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715102409af924ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715102409af924ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2450715018","title":"北向资金7月10日净卖出安图生物21.35万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450715018","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450715018?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:30","pubTimestamp":1720661434,"startTime":"0","endTime":"0","summary":"7月10日,北向资金减持安图生物21.35万股连续3日减持。截止当日收盘,沪股通共持有安图生物1277.76万股,占流通股2.19%。沪股通减持金额前五个股分别为赛力斯、北汽蓝谷、中国石化、中国铝业、伊利股份。安图生物近5个交易日下跌2.63%,沪股通累计减持104.55万股;近20个交易日下跌9.77%,沪股通累计减持298.65万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071109343395a2abfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071109343395a2abfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2450589989","title":"安图生物:7月9日高管苗拥军增持股份合计3000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450589989","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450589989?lang=zh_cn&edition=full","pubTime":"2024-07-10 20:01","pubTimestamp":1720612897,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月10日市场公开信息、上市公司公告及交易所披露数据整理,安图生物最新董监高及相关人员股份变动情况:2024年7月9日公司董事苗拥军共增持公司股份3000.0股,占公司总股本为0.0005%。安图生物近半年内的董监高及核心技术人员增减持详情如下:安图生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出169.48万,融资余额减少;融券净流入3.24万,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000042375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2449790684","title":"北向资金7月5日净买入安图生物4.22万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2449790684","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449790684?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:30","pubTimestamp":1720402230,"startTime":"0","endTime":"0","summary":"7月5日, 北向资金增持安图生物4.22万股,连续3日增持。截止当日收盘,沪股通共持有安图生物1394.59万股,占流通股2.40%。沪股通增持金额前五个股分别为国投电力、中金黄金、中国核电、川投能源、中国石油。安图生物近5个交易日下跌2.47%,沪股通累计减持24.38万股;近20个交易日下跌9.87%,沪股通累计减持422.16万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080933419f1b60b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080933419f1b60b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2448459442","title":"安图生物:7月3日高管苗拥军增持股份合计2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448459442","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448459442?lang=zh_cn&edition=full","pubTime":"2024-07-04 20:01","pubTimestamp":1720094495,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月4日市场公开信息、上市公司公告及交易所披露数据整理,安图生物最新董监高及相关人员股份变动情况:2024年7月3日公司董事苗拥军共增持公司股份2.0万股,占公司总股本为0.0034%。安图生物近半年内的董监高及核心技术人员增减持详情如下:安图生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出1190.01万,融资余额减少;融券净流入18.02万,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400039266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2448015541","title":"安图生物:7月2日高管苗拥军增持股份合计5.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448015541","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448015541?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:01","pubTimestamp":1720008070,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月3日市场公开信息、上市公司公告及交易所披露数据整理,安图生物最新董监高及相关人员股份变动情况:2024年7月2日公司董事苗拥军共增持公司股份5.5万股,占公司总股本为0.0095%。安图生物近半年内的董监高及核心技术人员增减持详情如下:安图生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出1106.61万,融资余额减少;融券净流入25.43万,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300041439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2448779571","title":"安图生物:\n公司目前生产经营一切正常,敬请投资者注意投资风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2448779571","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448779571?lang=zh_cn&edition=full","pubTime":"2024-07-03 18:02","pubTimestamp":1720000927,"startTime":"0","endTime":"0","summary":"证券之星消息,安图生物07月03日在投资者关系平台上答复投资者关心的问题。公司目前生产经营一切正常,敬请投资者注意投资风险。公司在二级市场的股票价格受行业政策情况、宏观经济环境、资本市场供给和投资者风险偏好等多方面因素共同影响,敬请投资者注意投资风险。关于公司二季度的经营情况,敬请关注公司拟于2024年8月21日披露的《安图生物2024年半年度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300037536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2448517263","title":"安图生物:公司目前生产经营一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2448517263","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448517263?lang=zh_cn&edition=full","pubTime":"2024-07-03 17:46","pubTimestamp":1719999977,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问公司是不是出现经营重大变故,为何股价跌跌不休,独立全行业的下跌是否隐藏重大利空?安图生物(603658.SH)7月3日在投资者互动平台表示,公司目前生产经营一切正常,敬请投资者注意投资风险。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703174640956d025e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703174640956d025e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2448411083","title":"北向资金7月2日净卖出安图生物25.67万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2448411083","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448411083?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:30","pubTimestamp":1719970233,"startTime":"0","endTime":"0","summary":"7月2日,北向资金减持安图生物25.67万股连续3日减持。截止当日收盘,沪股通共持有安图生物1377.81万股,占流通股2.35%。沪股通减持金额前五个股分别为工业富联、万华化学、紫金矿业、洛阳钼业、恒瑞医药。安图生物近5个交易日下跌2.37%,沪股通累计减持72.24万股;近20个交易日下跌11.45%,沪股通累计减持363.62万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030933289ef86b48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030933289ef86b48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2448592793","title":"安图生物获融资买入0.11亿元,近三日累计买入0.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448592793","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448592793?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:14","pubTimestamp":1719879253,"startTime":"0","endTime":"0","summary":"7月1日,沪深两融数据显示,安图生物获融资买入额0.11亿元,居两市第473位,当日融资偿还额0.15亿元,净卖出420.02万元。最近三个交易日,27日-1日,安图生物分别获融资买入0.05亿元、0.08亿元、0.11亿元。融券方面,当日融券卖出3.90万股,净卖出3.85万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070208141895626eb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070208141895626eb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2448916554","title":"安图生物董事苗拥军增持2.40万股,成交均价46.09元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448916554","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448916554?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:50","pubTimestamp":1719841843,"startTime":"0","endTime":"0","summary":"上交所公开信息显示,6月28日,安图生物董事苗拥军在二级市场买卖公司股票,增持股数2.40万股,成交均价46.09元,变动金额110.62万元,变动后持股数为114.31万股。近一个月来,安图生物共出现9次高管增持,增持总数241.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701215853955f74f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701215853955f74f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2448991461","title":"安图生物:6月28日高管苗拥军增持股份合计2.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448991461","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448991461?lang=zh_cn&edition=full","pubTime":"2024-07-01 20:01","pubTimestamp":1719835293,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月1日市场公开信息、上市公司公告及交易所披露数据整理,安图生物最新董监高及相关人员股份变动情况:2024年6月28日公司董事苗拥军共增持公司股份2.4万股,占公司总股本为0.0041%。安图生物近半年内的董监高及核心技术人员增减持详情如下:安图生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出806.34万,融资余额减少;融券净流入20.06万,融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100027216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2448619099","title":"安图生物:累计回购约412万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448619099","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448619099?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:21","pubTimestamp":1719825680,"startTime":"0","endTime":"0","summary":"每经AI快讯,安图生物 7月1日晚间发布公告称,截至2024年6月30日,公司通过集中竞价交易方式已累计回购股份约412万股,占公司总股本的比例为0.7032%,成交的最高价为59.99元/股、最低价为47.61元/股,已支付的总金额约为2.16亿元。2023年1至12月份,安图生物的营业收入构成为:体外诊断占比98.29%。截至发稿,安图生物市值为268亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701172152955dfbbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701172152955dfbbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2448969286","title":"安图生物(603658.SH)取得14项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2448969286","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448969286?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:11","pubTimestamp":1719825079,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安图生物(603658.SH)发布公告,公司于近日收到河南省药品监督管理局颁发的医疗器械注册证,本次共取得14项医疗器械注册证,进一步丰富了公司产品菜单,不断满足市场需求,是对公司现有检测产品的有效补充,可以逐步提高公司产品的整体竞争力,短期内对公司的经营业绩影响较小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1143604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","603658","09997","BK0046","BK0239","BK1100","BK1222","BK1583","09996","BK1574"],"gpt_icon":0},{"id":"2448961905","title":"安图生物最新公告:近日收到河南省药品监督管理局颁发的医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2448961905","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448961905?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:02","pubTimestamp":1719824521,"startTime":"0","endTime":"0","summary":"安图生物公告,于近日收到河南省药品监督管理局颁发的医疗器械注册证。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701170617955de07a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701170617955de07a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0046","159883","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","stockEarnings":[{"period":"1week","weight":-0.0442},{"period":"1month","weight":-0.1085},{"period":"3month","weight":-0.2437},{"period":"6month","weight":-0.0967},{"period":"1year","weight":-0.2606},{"period":"ytd","weight":-0.2525}],"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","perCapita":"25916股","boardName":"医药制造业","registeredCapital":"58101万元","compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0275},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1013},{"period":"ytd","weight":-0.0282}],"survey":" 郑州安图生物工程股份有限公司专业从事体外诊断试剂及仪器的研发、制造、整合及服务,产品涵盖免疫、微生物、生化等检测领域,同时也在分子检测等领域积极布局,能够为医学实验室提供全面的产品解决方案和整体服务。公司产品按照检测方法或应用领域分类,主要分为以下几类:免疫类诊断试剂、微生物检测试剂、生化检测试剂、分子检测试剂、免疫类、微生物类、分子类、临床检验及其他辅助设备。公司产品覆盖了从传染病到非传染病的诸多方向,是我国业内提供免疫检测产品较多的企业之一,也是国内能够提供全面免疫检测解决方案的企业之一。","serverTime":1722258453990,"listedPrice":14.58,"stockholders":"22419人(较上一季度减少6.18%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}